Introduction
============

Empirical evidence suggests that certain aspects of trial design may lead to biased intervention effect estimates. We examined the influence of risk-of-bias judgements from Cochrane reviews for sequence generation, allocation concealment, blinding and incomplete data on intervention effect estimates in a large collection of meta-analyses (MAs).

Methods
=======

We selected MAs with dichotomous outcomes and \> 4 included trials from intervention reviews with fully completed risk-of-bias tool, published in issue 4, 2011 of the Cochrane Library. We classified outcome measures as mortality, other objective or subjective, and estimated the effect of risk-of-bias domain judgements on average bias (ratios of odds ratios \[ROR\] with 95% credible intervals \[Cr-I\]) using Bayesian hierarchical models.

Results
=======

Among 2815 trials in 256 meta-analyses, intervention effect estimates were on average exaggerated in trials with high or unclear risk-of-bias (versus low) for random sequence generation (ROR 0.91 \[95% Cr-I 0.86, 0.98\]), for allocation concealment (ROR 0.92 \[95% Cr-I 0.86-0.98\]) and for blinding (ROR 0.87 \[95% Cr-I 0.80, 0.93\]). Unlike our previous study, we did not observe consistently different bias or between-trial heterogeneity in bias in MAs with subjective outcomes compared to mortality. Results from analyses of the influences of incomplete data were inconclusive.

Limitations
===========

Possible inconsistency in criteria for risk-of-bias judgments applied by individual reviewers is a likely limitation of routinely collected bias assessments.

Conclusions
===========

Inadequate randomization or lack of blinding may lead to exaggeration of intervention effect estimates in trials, but it is unclear if this effect differs by outcome type.
